---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-292621"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2023-12-11T23:59:59+00:00"
generated_at: "2026-06-07T14:40:46.784402+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Corcept amends bylaws to strengthen director nomination and meeting rules

## Summary
- Board can postpone, reschedule or cancel annual meetings even after notice has been sent to stockholders.
- Enhanced requirements for stockholder nominations and proposals; must comply with Rule 14a-19 and attend the meeting.
- Proxy card color rule: white cards reserved for Board; any other solicitation must use a different color.
- Eliminated requirement to make stockholder list available at meetings, aligning with recent Delaware law changes.
- Amendments effective December 5, 2023; govern meeting procedures and proxy solicitation mechanics.

## SEC filing metadata
- accession: 0001193125-23-292621
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2023-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/0001193125-23-292621-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/d833600d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-292621
- JSON: https://secwatch.observer/filing/0001193125-23-292621.json
- Plain text: https://secwatch.observer/filing/0001193125-23-292621.txt

## Key facts
- Governance Changes
  CORCEPT THERAPEUTICS INC: Amended and restated bylaws to allow postponement/rescheduling/cancellation of annual meetings, enhance director nomination and business proposal requirements, and address proxy solicitation mechanics (effective 2023-12-05).
  - Change: bylaw amendment
  - Effective: 2023-12-05
  source text: On December 5, 2023, the Board of Directors (the “Board”) of Corcept Therapeutics Incorporated (the “Company”) approved and adopted an amendment and restatement of the Company’s amended and restated bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective as of December 5, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/0001193125-23-292621-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.